Teva's CEO Shows He Means Business With Planned 25% Job Cuts - Bloomberg
Teva Pharmaceutical Industries Ltd's (ADR) (TEVA) GmbH and Alder BioPharmaceuticals Form Global License Agreement
TEVA PHARMACEUTICAL INDUSTRIES LIMITED : TEVA Stock Price | US8816242098 | MarketScreener
Settling a post-buyout hangover, Allergan gives Teva a $700M remedy | Fierce Pharma
Teva Pharm Q3 profit misses estimates, sees recovery into Q4 | Reuters
Morgan Stanley Downgrades Teva From Overweight to Equal Weight | Ctech
Is Teva Pharma's Restructuring Plan Actually 'More Reasonable'? | Investor's Business Daily
F.D.A. Approves Generic EpiPen That May Be Cheaper - The New York Times
Teva Flip Flops Mush : Target
Morgan Stanley says buy Teva because its turnaround is still in the 'early innings'
Teva Earnings Q3 2018 | AlphaStreet
Sex, Drugs, and Teva Pharmaceutical Industries (TEVA)
Teva Pharmaceutical (TEVA)
Brokerages have given Teva Pharmaceutical Industries Limited (NYSE:TEVA) a consensus rating of "Hold." - Best Stocks
UBS raises Teva price target - Globes
Allergan, Teva and others start 2018 with price hikes: analyst | Fierce Pharma
Teva Stock Upgraded After Earnings: What You Need to Know
Teva Pharmaceutical Stock: Gem Among Generic Pharma Companies (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical Stock: Prepare For Takeoff (NYSE:TEVA) | Seeking Alpha
Teva down as it reports lower sales and profit for 2018
Sell Teva Pharmaceutical due to increasing generic drugs competition: Credit Suisse
Why Teva Pharmaceuticals Stock Has Two A-Products In The Bag (NYSE:TEVA) | Seeking Alpha
Analysts see upside in Teva share price - Globes
